ArticleBMC pulmonary medicine2022

Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis.

Miriam Blasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.